Syngenta Moves to Calm Disappointed Shareholders 

Syngenta moved to appease shareholders angered by its rejection of a takeover from Monsanto, saying it will divest its global vegetables seeds business and return more than $2 billion to shareholders.

 
Novartis to Begin Selling Copy of Amgen's Neupogen in U.S. 

Novartis said it will begin selling the first biosimilar drug in the U.S. after an appeals court denied Amgen's request to block the Swiss drug maker's sale of its copycat version of blockbuster remedy Neupogen.

 
Australia Defers Decision on Shell's Takeover of BG 

Australia's antitrust regulator has given itself more time to consider Royal Dutch Shell's planned takeover of U.K.-based oil-and-gas firm BG Group.

 
Barclays Sells Portuguese Retail-Banking Business 

Barclays PLC has sold its Portuguese retail banking business to Spain's Bankinter SA, as the British bank scales back its presence in less profitable markets.

 
Shell, Exxon Must Pay Groningen Quake Compensation 

A Dutch court ruled that Royal Dutch Shell and Exxon Mobil must compensate homeowners for a drop in house prices caused by earthquakes linked to production at the Groningen gas field.

 
Private-Equity Firms Explore Bids for Petco 

Private-equity firms are examining a possible purchase of Petco Holdings, the pet-store chain that filed to go public last month.

 
Costco Same-Store Sales Rose Significantly in Fiscal 2015 

Costco Wholesale said sales in stores open at least a year grew significantly during fiscal 2015, adding to a string of strong sales figures for the warehouse retailer.

 
Lannett to Acquire UCB's Kremers Urban Unit 

Lannett Co. Inc. has agreed to buy UCB SA's Kremers Urban Pharmaceuticals Inc. for $1.23 billion.

(END) Dow Jones Newswires

September 03, 2015 06:13 ET (10:13 GMT)